Deborah Dunsire

Insider Reports History

Location
C/O Ultragenyx Pharmaceutical Inc., 60 Leveroni Court, Novato, CA
Signature
/s/ Sarah Ahmad Ali, Attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Deborah Dunsire:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Ultragenyx Pharmaceutical Inc. Director Common Stock 30.8K $1.17M $37.98 May 15, 2025 Direct
MCKESSON CORP Director Restricted Stock Units (RSUs) 301 $203K $580.92 Jul 30, 2025 Direct
Syros Pharmaceuticals, Inc. Director Common Stock 12K $59.4K $4.95 Jun 1, 2024 Direct
Syros Pharmaceuticals, Inc. Director Restricted Stock Units 4K $19.8K $4.95 Jun 5, 2024 Direct
Ultragenyx Pharmaceutical Inc. Director Stock Option (Right to Buy) 10.8K May 15, 2025 Direct
Syros Pharmaceuticals, Inc. Director Stock Option (right to buy) 6K Jun 5, 2024 Direct
ALEXION PHARMACEUTICALS, INC. Director Common Stock, par value $.0001 per share 0 $177.00 Jul 21, 2021 Direct

Insider Reports Filed by Deborah Dunsire

Symbol Company Period Transactions Value $ Form Type Date Filed Role
MCK MCKESSON CORP Jul 30, 2025 1 $0 4 Jul 31, 2025 Director
RARE Ultragenyx Pharmaceutical Inc. May 15, 2025 2 $0 4 May 19, 2025 Director
MCK MCKESSON CORP Jul 31, 2024 1 $0 4 Aug 1, 2024 Director
RARE Ultragenyx Pharmaceutical Inc. Jun 18, 2024 2 $0 4 Jun 20, 2024 Director
SYRS Syros Pharmaceuticals, Inc. Jun 5, 2024 2 $0 4 Jun 7, 2024 Director
MCK MCKESSON CORP Jun 3, 2024 1 $0 4 Jun 4, 2024 Director
MCK MCKESSON CORP Jun 3, 2024 0 $0 3 Jun 4, 2024 Director
SYRS Syros Pharmaceuticals, Inc. Jun 1, 2024 2 $0 4 Jun 4, 2024 Director
RARE Ultragenyx Pharmaceutical Inc. Jun 7, 2023 2 $0 4 Jun 9, 2023 Director
SYRS Syros Pharmaceuticals, Inc. Jun 1, 2023 2 $0 4 Jun 2, 2023 Director
SYRS Syros Pharmaceuticals, Inc. Sep 16, 2022 2 $0 4 Sep 19, 2022 Director
RARE Ultragenyx Pharmaceutical Inc. Jun 24, 2022 2 $0 4 Jun 28, 2022 Director
SYRS Syros Pharmaceuticals, Inc. Jun 1, 2022 1 $0 4 Jun 2, 2022 Director
SYRS Syros Pharmaceuticals, Inc. Sep 9, 2021 1 $0 4 Sep 10, 2021 Director
SYRS Syros Pharmaceuticals, Inc. Sep 9, 2021 0 $0 3 Sep 10, 2021 Director
ALXN ALEXION PHARMACEUTICALS, INC. Jul 21, 2021 1 $0 4 Jul 23, 2021 Director
RARE Ultragenyx Pharmaceutical Inc. Jun 24, 2021 2 $0 4 Jun 28, 2021 Director
ALXN ALEXION PHARMACEUTICALS, INC. May 20, 2021 2 $0 4 May 24, 2021 Director